BridgeMD
New treatment option for Overweight and/or Obesity
Official title Effects of Whole-Body High-Intensity Interval Training on Fitness in Overweight Adults
ClinicalTrials.gov ID: NCT07582718
What this study is testing
- What it's testing
- This study aims to evaluate the effects of a supervised whole-body high-intensity interval training (WB-HIIT) program on physical fitness and health outcomes in adults with overweight and obesity. WB-HIIT is a practical and time-efficient training modality based on body-weight exercises performed at high intensity with short recovery intervals.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Adults aged 18 to 55 years.
- Body mass index (BMI) between 25 and 35 kg/m².
- Able to provide written informed consent.
- Able to safely participate in high-intensity interval training.
- For participants with BMI \> 30 kg/m²: medical clearance from their general practitioner.
You likely can't join if
- BMI \ 35 kg/m².
- Presence of any chronic medical condition other than overweight/obesity.
- Known cardiovascular, metabolic, respiratory, or musculoskeletal disease that contraindicates high-intensity exercise.
- Pregnancy.
- Inability to perform exercise testing or complete the WB-HIIT program.
- Any condition judged by investigators to interfere with participation or data interpretation.
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.